Your browser doesn't support javascript.
loading
Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases.
Lamberg, Tea; Sipponen, Taina; Valtanen, Sanna; Eklund, Kari K; Mälkönen, Tarja; Aalto, Kristiina; Mikola, Katriina; Kolho, Kaija-Leena; Leinonen, Sanna; Isomäki, Pia; Mäkinen, Heidi; Vidqvist, Krista-Liisa; Kokko, Arto; Huilaja, Laura; Kyllönen, Minna; Keskitalo, Paula; Sard, Sirja; Vähäsalo, Paula; Koskela, Ritva; Kröger, Liisa; Lahtinen, Perttu; Haapala, Anna-Maija; Korkatti, Katja; Sokka-Isler, Tuulikki; Jokiranta, T Sakari.
Afiliación
  • Lamberg T; United Medix Laboratories, Helsinki, Finland.
  • Sipponen T; Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Valtanen S; Department of Gastroenterology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Eklund KK; United Medix Laboratories, Helsinki, Finland.
  • Mälkönen T; Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Aalto K; Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Mikola K; Orton Orthopedic Hospital Helsinki, Helsinki, Finland.
  • Kolho KL; Department of Dermatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Leinonen S; New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Isomäki P; New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Mäkinen H; Pediatric Gastroenterology, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Vidqvist KL; Tays Eye Centre, Tampere University Hospital, Tampere, Finland.
  • Kokko A; Centre for Rheumatology, Tampere University Hospital, Tampere, Finland.
  • Huilaja L; Centre for Rheumatology, Tampere University Hospital, Tampere, Finland.
  • Kyllönen M; Centre for Rheumatology, Tampere University Hospital, Tampere, Finland.
  • Keskitalo P; Department of Rheumatology, Jyväskylä Central Hospital, Jyväskylä, Finland.
  • Sard S; PEDEGO Research Unit, University of Oulu, Oulu, Finland.
  • Vähäsalo P; Department of Dermatology and Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Koskela R; Department of Rheumatology, Oulu University Hospital, Oulu, Finland.
  • Kröger L; PEDEGO Research Unit, University of Oulu, Oulu, Finland.
  • Lahtinen P; Department of Pediatrics, Oulu University Hospital, Oulu, Finland.
  • Haapala AM; Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Korkatti K; PEDEGO Research Unit, University of Oulu, Oulu, Finland.
  • Sokka-Isler T; Department of Pediatrics, Oulu University Hospital, Oulu, Finland.
  • Jokiranta TS; Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
Autoimmunity ; 55(5): 275-284, 2022 08.
Article en En | MEDLINE | ID: mdl-35481450

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Autoimmunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Autoimmunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia